|
||
Original Article |
leibson.paul{at}mayo.edu
| Abstract |
|---|
|
|
|---|
Key Words: natural killer cell signal transduction cytotoxicity, immunologic tyrosine kinase tyrosine phosphatase
However, it remains unclear if raft redistribution is simply caused by a passive aggregation of cross-linked receptors or if there is another level of regulation involved in raft redistribution. In this study, we evaluated the regulation of raft redistribution during the development of cell-mediated cytotoxicity. We used NK cells as a model because it has been well characterized in NK cells that both positive and negative signals critically regulate the development of cell-mediated cytotoxicity. NK cells are CD16+CD56+TCR–sIg– lymphocytes capable of killing certain tumor cells or virus-infected cells ("natural cytotoxicity"). Although receptors involved in the activation of NK cells during natural cytotoxicity are still poorly defined, it is known that downstream signaling molecules include PTKs, as well as Rho family low-molecular-mass G proteins, adaptor proteins, and calcium 111213141516.
NK cell activation is blocked when killer cell inhibitory receptors (KIRs) on the surfaces of NK cells engage MHC class I molecules on resistant target cells 11171819. This inhibition is mediated by KIR-associated SHP-1, a Src homology 2 (SH2) domain containing tyrosine phosphatase, that dephosphorylates and inactivates signaling molecules involved in NK cell activation 2021222324. This well characterized signaling model of NK cell activation enabled us to evaluate a potential regulatory role for specific signaling molecules in lipid raft reorganization. Furthermore, studies of NK cell–mediated cytotoxicity allowed us to evaluate lipid raft redistribution in a more physiological system in which NK cells are activated by direct contact with target cells. Using this experimental model, we have found that raft reorganization during the development of cell-mediated cytotoxicity depends on a balance between the positive and negative signals through opposing activities of proximal PTKs and phosphatases. Our results imply that raft polarization is a critical event during the development of cell-mediated cytotoxicity, and inhibiting raft redistribution is a novel mechanism of negative regulation mediated by inhibitory receptors.
Vaccinia Viruses.
Cytotoxicity Assays.
Raft Redistribution Assay.
![]()
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
A major portion of eukaryotic membranes is in a fluid, unordered state due to the low melting temperatures of glycerolipids. However, within the glycerolipid environment there are "islands" of sphingolipids that, unlike glycerolipids, have head groups capable of being both hydrogen bond donors and acceptors. This results in extensive lateral hydrogen bonding among sphingolipid head groups and much higher melting temperatures (40–80°C), which make "sphingolipid islands" an ordered population at physiological temperatures 1. These ordered fractions, known as lipid rafts, are relatively detergent resistant and, besides sphingolipids, contain cholesterol and a number of membrane-associated glycophosphatidylinositol-linked and fatty-acylated proteins 23. Lipid rafts have been implicated in immune cell activation 45678910. Key signaling molecules associate with lipid rafts, including protein tyrosine kinases (PTKs), heterotrimeric and small G proteins, adaptor proteins, and phosphoinositides 2345. Cross-linking of surface receptors in hematopoietic cells results in the enrichment of these receptors in the rafts along with other downstream signaling molecules, such as phospholipase C (PLC)
1, Vav, Zap70, and Syk 46789. Furthermore, rafts redistribute to and cluster at the site of TCR engagement when T cells are experimentally stimulated with beads coated with anti-CD3 and anti-CD28 antibodies 10. Based on these results, raft reorganization is proposed to be associated with T cell costimulation, presumably by recruiting signaling molecules and excluding phosphatases.
![]()
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Reagents, Cells, and Antibodies.
Unless otherwise indicated, all chemicals were from Sigma Chemical Co. Human NK cells were cloned and passaged as previously described 25. DX9+ NK cell clones were identified as previously described 15. The P815 murine mastocytoma cell line and the K562 human erythroid leukemia cell line were obtained from American Type Culture Collection. HLA class I–deficient 721 cells and HLA-B58 transfected 721 cells were provided by Peter Parham (Stanford University, Palo Alto, CA). Anti-p70 KIR mAb DX9 was provided by Lewis Lanier (DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA). Piceatannol was obtained from Boehringer Mannheim. PP1 was obtained from BIOMOL Research Labs., Inc. Herbimycin was obtained from GIBCO BRL.
Catalytically inactive SHP-C453S as well as pSC65 vector control have been described 20. KIR3DL was provided by Marcus Colonna (Basel Institute of Technology, Basel, Switzerland). Wild-type Syk and SykT were provided by Jean-Pierre Kinet and Andrew M. Scharenberg (Harvard Medical School, Boston, MA) 26.
The 51Cr-release assays measuring direct NK cell–mediated cytotoxicity were performed as previously described 25. Lytic units were calculated based on 20% cytotoxicity 27.
NK cells were stained for 30–45 min on ice with FITC–CTx (cholera toxin B subunit; 8 µg/ml). The labeled cells were washed twice in PBS containing 0.2% BSA and resuspended at a final concentration of 107 cells/ml for NK cells and 5 x 106 cells/ml for target cells. Equal volumes (50 µl) of NK cells and target cells were mixed, briefly pelleted, and then incubated for 5 min at 37°C. The cells were then fixed and transferred to glass slides by cytospin. NK cells that had formed conjugates were assessed for raft redistribution using a fluoromicroscope (Carl Zeiss, Inc.). A total of 50–100 conjugates was evaluated per slide, and the evaluation was performed by an individual blinded to the sample identities.
![]()
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Rafts Become Polarized during the Development of NK Cell–mediated Cytotoxicity.
Natural cytotoxicity is initiated after conjugate formation between an NK cell and a susceptible target. We examined lipid raft reorganization that rapidly ensues after this conjugate formation. As cholera toxin B subunit (CTx) binds GM1 ganglioside 28, a marker of glycolipid-enriched rafts, human NK cells were stained with FITC–CTx. After washing, NK cells were incubated with hydroethidine-labeled target cells at 37°C, fixed, and spun onto glass slides. Fig. 1 shows representative photographs of NK cell–target cell conjugates. When incubated with the NK-resistant cell line P815 (red), NK cell rafts (green) are dispersed throughout the plasma membrane (Fig. 1 A). In contrast, incubation of NK cells with the NK-sensitive cell line K562 results in reorganization of lipid rafts into "macrorafts" polarized at the area of contact with the sensitive target (Fig. 1 B).
|
|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The functional role of rafts during lymphocyte activation has been evaluated in several studies. The absence of detectable
and PLC
1 tyrosine phosphorylation and diminished calcium signals upon pharmacological disruption of rafts was interpreted as evidence for temporal order of events in which raft formation and polarization precedes activation of signal transduction cascade 6729303140. This view is supported by the observation that even cross-linking of glycophosphatidylinositol-linked peripheral membrane proteins can stimulate T cells, presumably through an increased local concentration of key signal transducing molecules 40414243. However, our data suggest that the polarization of lipid rafts is signaling dependent. Inhibition of the activity of Src or Syk family PTKs blocks reorganization of lipid rafts. Moreover, inhibitory signals initiated by KIR engagement also block raft polarization in an SHP-1–dependent manner. Because regulatory second messengers accumulate in rafts, and, at the same time, raft polarization depends on activation signals, it is likely that there is a positive feedback loop between raft aggregation and positive signal propagation. Instead of a unidirectional sequence of events (receptor cross-linking
raft aggregation
signal transduction), we believe that these three processes are interdependent. Lateral bonding between sphingolipids within rafts increases spatial rigidity of the receptor–ligand interactions. These rigid receptor–ligand interactions might then keep the signaling complex together for a longer time, which in turn might aggregate more sphingolipid-associated proteins into the cellular interphase and increase the probability of a complete cellular activation. Consistent with this notion, the interaction between cytoskeleton and lipid rafts has been proposed to increase raft stability 40, and a recent study suggests that the interaction between cytoskeleton and lipid rafts depends on tyrosine kinase activity 44. Furthermore, rafts are proposed to act as transporters of surface receptors and key signaling molecules during the formation of immunological synapses 10454647. This process has been shown to be driven by the movement of cytoskeleton and dependent on signal transduction 48.
KIRs block the activation of NK cells through SHP-1–mediated dephosphorylation of molecules involved in the activation cascade 20212223. Several direct targets of SHP-1 have been proposed 1524, but none of the current models have been able to fully explain the sequence of events during inhibitory signaling. Our data suggest that the negative signals mediated by KIRs arise during the earliest phase of NK activation, specifically before the formation of "macrorafts." Presumably, KIR-associated SHP-1 dephosphorylates and inactivates key signaling molecules that are required for the signal cascade leading to raft aggregation. On the other hand, aggregation of lipid rafts helps exclude phosphatase activity from the sites of positive signal propagation 1049. In our biochemical assays, neither KIRs nor SHP-1 could be detected in rafts (Jevermovic, D., Z. Lou, and P.J. Leibson, unpublished observation). Overall, the efficacy of raft redistribution and aggregation would ultimately be a function of the balance between positive and negative signals generated after interaction with specific target cells.
Our study provides new insights as to the regulatory events that critically influence the development of cell-mediated cytotoxicity. Lipid raft redistribution and polarization is regulated by positive and negative signals from the membrane receptors, and the integration of these signals can ultimately determine the commitment of cytotoxic lymphocytes to cellular cytotoxicity. This study also discloses a novel inhibitory mechanism that has the potential to be employed by certain homologous inhibitory receptors expressed on cells of both hematopoietic and nonhematopoietic lineages.
| Acknowledgments |
|---|
This research was supported by the Mayo Foundation and by National Institutes of Health grant CA47752. D.D. Billadeau is supported by a Levy Foundation Award and a Leukemia Society of America Special Fellows Award.
Submitted: 23 August 1999
Revised: 20 October 1999
Accepted: 16 November 1999
| References |
|---|
|
|
|---|
Brown D.A. & London E.. Functions of lipid rafts in biological membranes, Annu. Rev. Cell Dev. Biol., 14, 1998, 111–136.[Medline]
Harder T. & Simons K.. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains, Curr. Opin. Cell Biol., 9, 1997, 534–542.[Medline]
Simons K. & Ikonen E.. Functional rafts in cell membrane, Nature., 387, 1997, 569–572.[Medline]
Zhang W., Trible R.P. & Samelson L.E.. LAT palmitoylationits essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation, Immunity, 9, 1998, 239–246.[Medline]
Hope H.R. & Pike L.J.. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains, Mol. Biol. Cell, 7, 1996, 843–851.[Abstract]
Montixi C., Langlet C., Bernard A.-M., Thimonier J., Dubois C., Wurbel M.-A., Chauvin J.-P., Pierres M. & He H.-T.. Engagement of T cell receptor triggers its recruitment to low density detergent-insoluble membrane domains, EMBO (Eur. Mol. Biol. Organ.) J., 17, 1998, 5334–5348.[Medline]
Xanier R., Brennan T., Li Q., McCormack C. & Seed B.. Membrane compartmentation is required for efficient T cell activation, Immunity, 8, 1998, 723–732.[Medline]
Field K.A., Holowka D. & Baird B.. Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains, J. Biol. Chem., 272, 1997, 4276–4280.
Stauffer T.P. & Meyer T.. Compartmentalized IgE receptor–mediated signal transduction in living cells, J. Cell Biol., 139, 1997, 1447–1454.
Viola A., Schroeder S., Sakakibara Y. & Lanzavecchia A.. T lymphocyte costimulation mediated by reorganization of membrane microdomains, Science., 283, 1999, 680–682.
Leibson P.J.. Signal transduction during natural killer cell activationinside the mind of a killer, Immunity., 6, 1997, 655–661.[Medline]
Brumbaugh K.M., Binstadt B.A. & Leibson P.J.. Signal transduction during NK cell activationbalancing opposing forces, Curr. Topics Microbiol. Immunol, 230, 1998, 103–122.[Medline]
Billadeau D.D., Brumbaugh K.M., Dick C.J., Schoon R.A., Bustelo X.R. & Leibson P.J.. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing, J. Exp. Med., 188, 1998, 549–559.
Brumbaugh K.M., Binstadt B.A., Billadeau D.D., Schoon R., Dick C.J., Ten R.M. & Leibson P.J.. Functional role for syk tyrosine kinase in natural killer cell–mediated natural cytotoxicity, J. Exp. Med., 186, 1997, 1965–1974.
Binstadt B.A., Billadeau D.D., Jevremovic D., Williams B.L., Fang N., Yi T., Koretzky G.A., Abraham R.T. & Leibson P.J.. SLP-76 is a direct substrate of SHP-1 recruited to killer inhibitory receptors, J. Biol. Chem., 273, 1998, 27518–27523.
Jevremovic D., Billadeau D.D., Schoon R.A., Dick C.J., Irvin B.J., Zhang W., Samelson L.E., Abraham R.T. & Leibson P.J.. A role for the adaptor protein LAT in human NK cell-mediated cytotoxicity, J. Immunol., 162, 1999, 2453–2456.
Lanier L.L.. Natural killer cellsfrom no receptors to too many, Immunity., 6, 1997, 371–378.[Medline]
Long E.O.. Regulation of immune response through inhibitory receptors, Annu. Rev. Immunol., 17, 1999, 875–904.[Medline]
Colonna M.. Specificity and function of immunoglobulin superfamily NK cell inhibitory receptors and stimulatory receptors, Immunol. Rev., 155, 1997, 127–134.[Medline]
Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.-P. & Long E.O.. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor, Immunity., 4, 1996, 77–85.[Medline]
Binstadt B.A., Brumbaugh K., Dick C.J., Scharenberg A.M., Williams B.L., Colonna M., Lanier L.L., Kinet P.-J., Abraham R.T. & Leibson P.J.. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation, Immunity, 5, 1996, 629–638.[Medline]
Campbell K.S., Dessing M., Lopez-Botet M., Cella M. & Colonna M.. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein phosphatase 1C, J. Exp. Med., 184, 1996, 93–100.
Fry A.M., Lanier L.L. & Weiss A.. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C, J. Exp. Med., 184, 1996, 295–300.
Valiante N.M., Phillips J.H. & Lanier L.L.. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-
signaling complex in human natural killer (NK) cells, J. Exp. Med., 184, 1996, 2243–2250.
Windebank K.P., Abraham R.T., Powis G., Olsen A., Barna T.J. & Leibson P.J.. Signal transduction during human natural killer cell activationinositol phosphate generation and regulation by cyclic AMP, J. Immunol., 141, 1988, 3951–3957.[Abstract]
Scharenberg A.E., Lin S., Cuerod B., Yamamura H. & Kinet J.-P.. Reconstitution of interaction between tyrosine kinases and the high affinity IgE receptor which are controlled by receptor clustering, EMBO (Eur. Mol. Biol. Organ.) J., 14, 1995, 3385–3394.[Medline]
Pross H.F., Callewaert D. & Rubin P.. Assay for NK cell cytotoxicity—their values and pitfalls, Lotzova E. & Herberman R.B., Immunobiology of Natural Killer Cells. Vol. 1, 1986, 2–20, CRC Press, Inc., Boca Raton, FL.
Schon A. & Freire E.. Thermodynamic of intersubunit interactions in cholera toxin upon binding to oligosaccharide portion of its cell surface receptor, ganglioside GM1, Biochemistry., 28, 1989, 5019–5024.[Medline]
Klein U., Gimpl G. & Iahrenholz F.. Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor, Biochemistry., 34, 1995, 13784–13793.[Medline]
Sheets E.D., Holowka D. & Baird B.. Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of Fc
RI and their association with detergent-resistant membranes, J. Cell Biol., 145, 1999, 877–887.
Stulnig T.M., Berger M., Sigmund T., Raederstorff D., Stockinger H. & Waldhausl W.. Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains, J. Cell Biol., 143, 1998, 637–644.
Uehara Y., Hori M., Takeuchi Y. & Umezawa H.. Screening of agents which convert transformed morphology of Rous sarcoma virus-infected rat kidney cells to normal morphologyidentification of an active agent as herbimycin and its inhibition of src kinase, Jpn. J. Cancer Res., 76, 1985, 672–675.[Medline]
Uehara Y., Hori M., Takeuchi T. & Umezawa H.. Phenotypic change from transformed to normal induced by benzoquinonoid ansamycin accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus, Mol. Cell. Biol., 6, 1986, 2198–2206.
Uehara Y., Murakami Y., Sugimoto Y. & Mizuno S.. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin Areduction of total phosphorylation levels due to reduced kinase activity and increased turnover of p60v-src 1, Cancer Res., 49, 1989, 780–785.
Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A. & Connelly P.A.. Discovery of a novel, potent and Src family-selective tyrosine kinase inhibitor. Study of Lck- and Fyn-dependent T cell activation, J. Biol. Chem., 271, 1996, 695–701.
Oliver J.M., Burg D.L., Wilson B.S., McLaughlin J.L. & Geahlen R.L.. Inhibition of mast cell Fc
R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol, J. Biol. Chem., 269, 1994, 29697–29703.
Litwin V., Gumperz J., Parham P., Phillips J.H. & Lanier L.L.. NKB1a natural killer receptor involved in the recognition of polymorphic HLA-B molecules, J. Exp. Med., 180, 1994, 537–543.
Gumperz J.E., Litwin V., Phillips J.H., Lanier L.L. & Parham P.. The BW4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor, J. Exp. Med., 181, 1995, 1133–1144.
Gumperz J.E., Barber L.D., Valiante N.M., Percival L., Phillips J.H., Lanier L.L. & Parham P.. Conserved and variable residues within the BW4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor, J. Immunol., 158, 1997, 5237–5241.[Abstract]
Moran M. & Miceli M.C.. Engagement of GPI linked CD48 contributes to TCR signals and cytoskeleton reorganizationa role for lipid rafts in T cell activation, Immunity., 9, 1998, 787–796.[Medline]
Yeh E.T., Reiser H., Bamezai A. & Rock K.L.. TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptor, Cell., 52, 1988, 665–674.[Medline]
Schubert J., Stroehmann A., Schoiz C. & Schmidt R.E.. Glycophosphatidylinositol (GPI)-anchored surface antigens in the allogeneic activation of T cells, Clin. Exp. Immunol., 102, 1995, 199–203.[Medline]
Romagnoli P. & Bron C.. Phosphatidylinositol-based glycolipid-anchored proteins enhance proximal TCR signaling events, J. Immunol., 158, 1997, 5757–5764.[Abstract]
Harder T. & Simon K.. Clusters of glycolipid and glycosylphosphosphatidylinositol-anchored proteins in lymphoid cellsaccumulation of actin regulated by local tyrosine phosphorylation, Eur. J. Immunol., 29, 1999, 556–562.[Medline]
Dustin A.S. & Shaw M.L.. Costimulationbuilding an immunological synapse, Science., 283, 1999, 649–650.
Lanzavecchia A., Lezzi G. & Viola A.. From TCR engagement to T cell activationa kinetic view of T cell behavior, Cell., 96, 1999, 1–4.[Medline]
Shaw M. & Dustin M.L.. Making the T cell receptor go the distancea topological view of the T cell activation, Immunity., 6, 1997, 361–369.[Medline]
Wulfing C. & Davis M.M.. A receptor/cytoskeletal movement triggered by costimulation during T cell activation, Science., 282, 1998, 2266–2269.
Rogers W. & Rose J.K.. Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains, J. Cell Biol., 135, 1996, 1515–1523.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|